Kidney Function Tests Market: Introduction
- Kidneys are among the most vital organs of the human body. Kidneys acts as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the blood. Kidneys play an important role in the body. Hence, they require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth, otherwise they become vulnerable to cancerous tumors and metastasis. The functional damage of the kidney is common across the world and its incidence is increasing. The symptoms which indicate a problem related to kidneys include high blood pressure, blood in urine, difficulty in urination, frequent urges to urinate, and swelling in the hands and feet due to a buildup of fluids in the body.
- Kidney function tests, or renal tests, can be categorized into concentration & dilution tests, clearance tests (provide an assessment of the filtration rate of the glomeruli, the principal filtering structures of the kidneys and whole renal blood flow), visual & physical examination of urine, and determination of the concentration of numerous substances in the urine, such as glucose, phosphate, sodium, amino acids, and potassium, to help detect possible impairment of the specific kidney functions generally involved with their reabsorption.
Key Drivers, Restrains, and Opportunities of Global Kidney Function Tests Market
- Increase in incidence and prevalence of chronic kidney disease across the world is a major factor boosting the growth of the global kidney function tests market. According to the Global Burden of Disease Study, 697.5 million cases of chronic kidney disease (CKD) were recorded across the world in 2017. China (132 million cases) and India (115 million cases) accounted for nearly a third of all CKD cases. Therefore, rise in prevalence of chronic kidney disease (CKD) is projected to fuel the growth of the global kidney function tests market.
- Moreover, public-private organizations are working to make kidney disease diagnostics more accessible in key areas. For example, in July 2020, the National Kidney Foundation (NKF) and the National Committee for Quality Assurance (NCQA) released a new kidney health evaluation measure designed exclusively for diabetic patients. The new guidelines recommend that diabetic patients be tested for kidney damage on a regular basis. These activities are expected to generate a favorable environment for market expansion. However, increase in stringent regulatory approvals and health care expenditure are factors expected to hamper the growth of the global kidney function tests market in the near future.
- According to various studies, the coronavirus has an impact on patients' kidney function. According to a recent kidney and blood pressure research, over 40% of admitted COVID-19 patients showed symptoms of abnormal kidney function, such as albuminuria or hematuria. According to a research published by the National Kidney Foundation, COVID-19 patients were twice as likely as non-COVID-19 individuals to develop acute kidney injury (AKI). According to health officials, COVID-19 patients with an AKI are recommended to get tested on a regular basis, as per health officials, because their risk of developing CKD is higher than that of other patients. These factors are likely to propel the global kidney function tests market.
North America to Capture Major Share of Global Kidney Function Tests Market
- North America is projected to account for major share of the global kidney function tests market during the forecast period owing to high prevalence of the disease, especially in the U.S., well-established healthcare infrastructure, and high affordability and awareness levels of the people in this region.
- The kidney function tests market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. This is attributed to increase in number of high blood pressure and diabetes patients, who develop chronic kidney diseases, rise in health awareness, and surge in demand for advanced diagnostic and therapeutic regimens for chronic kidney diseases in the region.
Key Players Operating in Global Kidney Function Tests Market
The global kidney function tests market is highly competitive and mature due to the participation and presence of several established as well as new players.
Major players operating in the global kidney function tests market are:
- F. Hoffmann-La Roche Ltd.
- Galectin Therapeutics, Inc.
- Baxter International Inc.
- Otsuka Holdings Co., Ltd.
- Eli Lilly and Company
- Siemens Healthineers
- Abbott Laboratories
- Sysmex Corporation
- Randox Laboratories
- Other Prominent Players
Global Kidney Function Tests Market: Research Scope
Global Kidney Function Tests Market, by Product
- Dipsticks
- Reagents
- Disposables
Global Kidney Function Tests Market, by End-user
- Hospitals
- Diagnostics Laboratories
- Research Laboratories & Institutes
Global Kidney Function Tests Market, by Test Type
- Urine Tests
- Blood Tests
- Dilution & Concentration Tests
- Other Tests
Global Kidney Function Tests Market, by Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
